Progress, Potential, and Possibilities Podcast / Show · 2026-05-18 · 51 min
Send us Fan Mail We used to think of DNA as something we read. Now we’re starting to treat it like something we write - and that changes everything about how medicine gets made. Dr. Patrick Finn, Ph.D. is President and COO of Twist Bioscience ( ), a company that’s helping turn biology into something you can engineer, iterate, and even industrialize. Dr. Finn has spent his entire career building the infrastructure layer of modern biotech - from sequencing and sample prep at Beckman Coulter and Invitrogen, to scaling commercial platforms at Agilent Technologies and now Twist. Dr. Finn also served as Vice President of Sales and Marketing for Enzymatics (recently acquired by QIAGEN), leading commercial activities for North America and Europe, delivering significant top line growth and expanding the base of business to business customers. So this isn’t just a conversation about the future - it’s about how the tools that make the future possible are actually built and deployed. On this episode we go beyond the buzzwords and dig into what it really means to “program biology”, and how close we actually are to designing medicines the way we design software.
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
Medicare Negotiates Like an Owner. Commercial Doesn’t.Value Based Care Advisory (VBCA) Podcast · on AI in healthcare93 / 100
How Healthcare Moves from Reactive Care to Preventive with Ray PawlickiBiology Matters · on AI in healthcare83 / 100
The Scientist Turned VC Funding the Cure for Aging with Omri Amirav-DroryVentures from The Valley · on Biotech81 / 100
Ep. 108 - Where Did All the Doctors Go? A Surgeon and Medical School Dean on What We’re Losing (ft. Dr. Chad Perlyn)Working Healthcare · on AI in healthcare80 / 100
World's Leading Safe AI Expert: Superintelligence Will Change Everything & It's Closer Than You Think! - Dr. Craig A. KaplanFour Fs Podcast · on Artificial intelligence74 / 100
101: Rapid Transformation - AI, Psychedelics & Leadership with Dr Catriona WallaceHabits of Leadership · on Artificial intelligence73 / 100Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100The Blood Test That Could Change Cancer Treatment Forever | Eric Matthews - General Manager, Biopharma, Natera65 / 100How Female Biology Shapes Skin Disease Across a Lifetime | Dr. Doral Fredericks, PharmD, MBA - Vice President and Head of Global Medical Affairs and Outcomes Research, Organon56 / 10055 Years Without a Diagnosis | Can AI Solve The Undiagnosed Condition Blind Spot? | Haresh Patel - Founder and CEO, Sanare Health AI70 / 100How Regenerative Medicine Is Reinventing Breast Reconstruction | Dr. Claudia Chavez-Munoz, MD, PhD - Chief Scientific Officer and Co-Founder - Conexeu Sciences